BrokeIt - Startup Drama · All episodes: ↗

Virus halts cancer, AI solves black holes, Russia spies Silicon Valley

2026-11-20 · 7 min

Listen · Apple Podcasts Listen · Spotify

Stories covered

Transcript

Intro

Nora: A custom virus, injected right into a tumor, has halted pancreatic cancer in three patients. It just... stopped it.

Dex: This is Dex.

Nora: And this is Nora.

Dex: You're listening to Startup Drama. It's Friday, November 20th, and we have three wild stories lined up for you.

Nora: Let's get into it.

Dex: We're going to unpack an incredible biotech breakthrough in cancer treatment.

Nora: Followed by an AI model that supposedly solved open problems in black hole physics. We'll see about that.

Dex: And we've got a story ripped straight from a spy novel: a Russian agent caught red-handed inside a Silicon Valley deep tech company.

Pancreatic cancer halted by virus injection in three patients

Dex: Alright, let's start there. New Scientist is reporting that researchers halted pancreatic cancer in three patients with a virus injection. This is just... monumental.

Nora: Okay, let's pump the brakes slightly. It is incredible, but this is a Phase 1 trial. Tiny sample size. The headline is 'halted,' not 'cured'.

Dex: But Nora, it's pancreatic cancer! The survival rates are abysmal. Halting tumor growth at all is a massive win. We're talking about a custom-engineered oncolytic virus here.

Nora: Right, a modified Poxvirus. It's designed to infect and kill cancer cells while triggering the patient's immune system to attack the tumor. It's fascinating science.

Dex: It's more than fascinating, it's personalized medicine in action. They tailored the virus for this. It's not off-the-shelf chemo.

Nora: And that's the part that gives me pause, commercially speaking. The cost and complexity of creating a custom virus for every patient... that's a huge hurdle.

Dex: For now! But this is how it starts. Remember how expensive gene sequencing was? Costs come down. This is the proof of concept.

Nora: The proof of concept is that in three patients, the tumors stopped growing. They didn't vanish. We don't know the long-term effects. We don't know if it will work in a fourth patient.

Dex: You're not wrong, but you're missing the hope here. For founders and investors in biotech, this is a signal that these moonshots are worth taking.

Nora: So, the takeaway? If you're a biotech founder, your insane idea might just work. It also means you have a decade-long, billion-dollar journey ahead of you.

Dex: And for the rest of us, it means the future of medicine is being built right now, one trial at a time. I'm choosing to be optimistic. This is incredible.

Claude solves two open problems in the physics of black holes

Nora: Alright, on to AI. Anthropic is claiming their model, Claude, solved two open problems in the physics of black holes.

Dex: YES! I love this. This is the singularity peeking through. AI isn't just for marketing copy anymore; it's accelerating fundamental science.

Nora: Hold on. It didn't wake up one morning and 'decide' to study physics. The researchers fed it a huge library of physics papers and prompted it very, very specifically.

Dex: But it worked! It found a variable in a ridiculously complex equation that human physicists missed. It connected the dots.

Nora: It found a needle in a haystack that we gave it. It's a phenomenally powerful pattern-matcher. Call it a 'scientific discovery search engine.' Calling it a 'physicist' is a stretch.

Dex: A stretch? Nora, this is a non-human intelligence finding novel solutions to problems humans have been stuck on for years. What else would you call it?

Nora: I'd call it a very advanced tool. An incredible tool, sure. But the framing from Anthropic is pure hype. It's just marketing.

Dex: It's marketing that happens to be true! This changes the game for research. Imagine feeding an AI all of medical research and just asking it to find new drug targets.

Nora: Okay, that's the real story here. It's not that we have robot Einsteins. It's that every R&D department now needs an AI strategy. How can these models accelerate what their human researchers are already doing?

Dex: Exactly. AI becomes a force multiplier for our own ingenuity. This is huge for deep tech startups. It could lower the barrier to discovery.

Nora: If you can afford the compute and the PhDs to run the prompts. That barrier is still pretty high.

Man hired by Russia spied on Silicon Valley tech and defense company, feds say

Dex: Alright, our last story is wild. The feds just charged a man with spying on a Silicon Valley tech and defense company... for Russia.

Nora: It was only a matter of time. Where there's valuable IP, there are spies. It's the second oldest profession.

Dex: The Ars Technica report says a Russian national got a job at the company specifically to steal trade secrets. We're talking quantum computing, defense tech... the serious stuff.

Nora: And let me guess, he wasn't exactly James Bond. These guys usually get caught doing something dumb, like using their work computer to email their handler.

Dex: Details are still coming out, but yeah, his opsec was not great. The indictment mentions encrypted channels, but the FBI obviously cracked them or had an informant. This is some serious stuff.

Nora: So the lesson for founders, especially in deep tech or dual-use: your threat model isn't just the competitor down the street. It's nation-states. And they are actively trying to recruit your employees.

Dex: A background check isn't going to cut it. You need real counter-intelligence thinking. Who has access to what? How are you monitoring for data leaving your network?

Nora: It's a nightmare. You're trying to build a collaborative, fast-moving startup culture, and suddenly you have to think like the CIA.

Dex: That's the cost of doing business when you're working on world-changing tech. Someone will always try to steal it instead of building it.

Dex: Alright, so to recap: a huge, if early, breakthrough in cancer treatment using a personalized virus.

Nora: An AI model acting as a super-powered research assistant for physicists, soon to be marketed as the next Einstein.

Dex: And a real-life spy story in Silicon Valley, reminding everyone that the tech Cold War is very, very real.

Nora: You know, Dex, with AI solving physics and viruses curing cancer, that Russian spy story almost feels... quaint. Nostalgic, even.

Dex: You find corporate espionage... nostalgic? Only you, Nora. I'm just glad they caught the guy.

Nora: I'm sure his replacement will have better opsec.

Dex: And that's our show! Thanks for listening to Startup Drama. We'll be back tomorrow.

Nora: Try not to get recruited by any foreign intelligence agencies before then.

This show is made with AI: the hosts’ voices are synthetic and the scripts are AI-assisted. Every story links to its original source.